Physician profile
Barry E Shapiro
NPI 1316949720
$9,302.73
in general payments reported to CMS, 2019-2025
33 companies · $353 in 2025
The $353 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,486 · 2020: $1,053 · 2021: $2,123 · 2022: $1,664 · 2023: $1,400 · 2024: $224 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926 · Travel and Lodging: $51.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.78 |
| Travel and Lodging | $51.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,950.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $865.39 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $795.49 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $719.49 | 2020-2023 | Farxiga, Brilinta, Wainua |
| Pfizer INC. | $670.22 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $649.46 | 2021-2025 | Optimizer, Optimizer |
| Merck Sharp & Dohme LLC | $462.00 | 2021-2024 | Verquvo |
| Amarin Pharma, INC. | $461.12 | 2019-2021 | |
| Esperion Therapeutics, INC. | $376.17 | 2020-2023 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $342.88 | 2020-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $335.20 | 2020-2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $317.65 | 2021-2023 | |
| Amgen INC. | $253.06 | 2019-2023 | Repatha |
| W. L. Gore & Associates, INC. | $240.18 | 2020-2022 | |
| Abbott Laboratories | $157.30 | 2021-2024 | Aveir |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $85.61 | 2020-2023 | |
| Heartflow, INC. | $68.33 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $56.45 | 2021-2023 | Arcalyst |
| Novo Nordisk INC | $55.56 | 2021 | |
| Stryker Corporation | $51.00 | 2024 | Mako |
| Actelion Pharmaceuticals US, INC. | $45.93 | 2023 | Opsumit, Uptravi |
| United Therapeutics Corporation | $45.48 | 2024-2025 | Tyvaso, Tyvaso |
| Kowa Pharmaceuticals America, INC. | $45.19 | 2021-2023 | Seglentis |
| Atricure, INC. | $35.70 | 2023 | |
| Medtronic, INC. | $34.09 | 2021-2022 | |
| Daiichi Sankyo INC. | $28.99 | 2023 | Injectafer |
| Kestra Medical Technology Services, INC. | $28.07 | 2023 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.92 | 2023 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $23.79 | 2023 | Inpefa |
| Cmp Pharma, INC. | $21.68 | 2021 | |
| Boston Scientific Corporation | $20.89 | 2025 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $18.23 | 2023 | Evkeeza |
| Genzyme Corporation | $14.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.